{"id":"W2953981643","doi":"10.1200/jco.2019.37.15_suppl.7505","title":"Polatuzumab vedotin (Pola) + obinutuzumab (G) and lenalidomide (Len) in patients (pts) with relapsed/refractory (R/R) follicular lymphoma (FL): Interim analysis of a phase Ib/II trial.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Internal medicine; Neutropenia; Tolerability; Follicular lymphoma; Adverse effect; Gastroenterology; Febrile neutropenia; Surgery; Lymphoma; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002774239,0.0009123481,0.001507684,0.0003247286,0.0003289679,0.0009501274,0.0007340771,0.0008149683,0.00255894],"category_scores_gemma":[0.0009076634,0.0004058093,0.001176467,0.0004436446,0.0005025012,0.0006730327,0.0004040853,0.002054092,0.0007466222],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009197061,"about_ca_system_score_gemma":0.001561673,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006658775,"about_ca_topic_score_gemma":0.001513543,"domain_scores_codex":[0.9994153,0.000310211,0.00004308169,0.00007170999,0.00004097654,0.000118746],"domain_scores_gemma":[0.9992852,0.0001330534,0.0001610252,0.00008453221,0.00003763693,0.0002986354],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8298499,0.01935101,0.01622023,0.0005329225,0.001375817,0.0003159146,0.0002255187,0.003109869,0.02216712,0.0002551808,0.003441914,0.1031546],"study_design_scores_gemma":[0.5359716,0.4181805,0.02756444,0.00006977106,0.001482434,0.0005612914,0.00006568414,0.001405242,0.007164241,0.000305764,0.007197434,0.00003141674],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9887179,0.003071616,0.0006256679,0.0005165688,0.00007695164,0.002399527,0.001964282,0.00009971872,0.002527727],"genre_scores_gemma":[0.9875833,0.001120574,0.002123531,0.0006926784,0.000118337,0.002364368,0.004017257,0.00002804072,0.001951944],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002774239,"threshold_uncertainty_score":0.01467174,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04840317173428456,"score_gpt":0.4044439827550674,"score_spread":0.3560408110207829,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}